Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed)
“The practical question isn’t whether this is something to celebrate, it’s whether your business is positioned to be a consolidator, an attractive acquisition target or something different.” By Christopher B. Lynch, Dickinson Wright PLLC There are a lot of rumors and misinformation out there about what the April 23 federal marijuana rescheduling order means. Some […]
How Cannabis Companies Can Take Advantage Of The Research And Development Tax Credit Under Federal Rescheduling (Op-Ed)
“Cannabis companies should consider various pitfalls to ensure not only legal compliance, but to maximize potential benefits.” By Meeren Amin, William Bogot and Douglas W. Charnas, Fox Rothschild LLP With rescheduling of medicinal marijuana and potential relief coming for recreational use, cannabis companies should be aware of tax benefits available to the industry. One such […]
Reports Of Increases In Problematic Cannabis Use Don’t Mean We Should Return To Prohibition (Op-Ed)
“A free society should be capable of learning to live with potentially risky substances without the government banning them.” By Jeffrey A. Singer, Cato Institute As a physician, I don’t dismiss recent reports of increases in problematic cannabis use. But we should avoid letting them trigger another drug-war moral panic. Cannabis use has increased as […]
Too Many People On Probation And Parole Still Can’t Use Medical Marijuana, Even Under Federal Rescheduling And State Legalization (Op-Ed)
“Because marijuana use remains illegal under federal law, standard supervision conditions may prohibit consumption.” By Sephria Reynolds-Tanner, Reason Foundation Medical marijuana is legal in 47 states, the District of Columbia and three U.S. territories. Yet for millions of Americans on probation or parole suffering from qualifying conditions like chronic pain, post-traumatic stress disorder and anxiety, […]
The Cannabis Industry Should Join Us In Supporting Hemp Drink Regulation Over Prohibition, Alcohol Industry Lobbyist Says (Op-Ed)
“Opposing a workable regulatory structure because it is not comprehensive cannabis reform risks repeating the very piecemeal approach the cannabis sector has spent years criticizing.” By Dawson Hobbs, Wine & Spirits Wholesalers of America The cannabis industry has spent years asking Congress for something more durable than prohibition, enforcement discretion and state-by-state improvisation. That is […]
Texas Officials Call Hemp A Crisis While Bigger Public Safety Threats Go Unanswered (Op-Ed)
“Texas can protect children and consumers without rebuilding the drug war.” By Michael A. Davis Texas officials have spent years treating hemp-derived THC as if it were the greatest danger facing the state. Now the crackdown is no longer political theater. Beginning July 31, Texas restored a controlled substance schedule that allows products labeled as […]
Congress Can Learn Lessons About The Hemp Debate From North Carolina’s Experience (Op-Ed)
“Lawmakers have an opportunity to build a regulatory framework that protects consumers while preserving access to products that millions of Americans already use.” By Chris Karazin, Carolindica Running a hemp business in North Carolina has become an exercise in navigating uncertainty. During the past year, it feels like I have spent almost as much time […]
Cannabis Companies Should Stop Teaming Up With Prohibitionists To Ban Hemp THC Products (Op-Ed)
“Cannabis lobbying groups are arming prohibitionists by demonizing hemp—helping those who have been at war with cannabis for decades… I’ve rarely seen a more self-defeating campaign.” By Aaron Edelheit, Mindset Capital Are cannabis organizations working to advance reform? Or are they arming the very prohibitionists who want to stop all THC commerce? Some regulated cannabis […]